Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of clinical efficacy between fluticasone propionate/formoterol and fluticasone furoate/vilanterol in asthma
jRCTs031180093Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of fluticasone propionate + formoterol and fluticasone propionate + vilanterol in asthma (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoint: Time to achieve well-controlled asthma after switching to ICS/LABA. Started Mar 2018; status: completed.
02
Drugs
fluticasone propionate + formoterolfluticasone propionate + vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on jRCTs031180093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180093.